Tirzepatide 30mg

$89.00

Trizepatide 30mg is a synthetic research peptide supplied for controlled laboratory studies of dual incretin-receptor activity, glucose-dependent signaling, and metabolic pathway coordination. Its modified molecular design supports investigations involving both GIP and GLP-1 receptors within qualified analytical and preclinical research settings.

Terms & Conditions

Privacy Policy

Research Use Disclaimer:
This product is supplied strictly for laboratory and scientific research purposes only. It is not intended for human consumption, medical treatment, diagnostic use, or veterinary applications. Purchasers are responsible for ensuring compliance with all applicable laws and regulations regarding the handling and use of research materials.

Description

Each Owens Peptide Solutions vial provides 30mg of lyophilized Trizepatide for qualified scientific research. The peptide is designed as a dual agonist of the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor.

Research Use Disclaimer:

For laboratory and research use only. Not intended for human or animal consumption, medical use, diagnostic use, veterinary use, or therapeutic application.

Its structure incorporates a fatty diacid component associated with reversible albumin binding and greater stability in experimental systems. These characteristics allow researchers to study prolonged receptor interaction, dual incretin signaling, and peptide pharmacology under controlled laboratory conditions.

Preclinical investigations have examined glucose-dependent cellular responses, insulin and glucagon pathway activity, receptor binding, and broader metabolic signaling. Findings remain dependent on the selected model and should not be interpreted as confirmed clinical outcomes.

Key Features

Dual incretin profile: Supports GIP and GLP-1 receptor studies.
30mg research quantity: Each vial contains 30mg of peptide.
Modified molecular design: Includes an albumin-binding structural component.
Extended experimental stability: Supports prolonged activity research models.
Lyophilized presentation: Freeze-dried for controlled laboratory handling.
Documented product identity: Supplied with lot and batch information.

Research Applications

Trizepatide may be evaluated in laboratory studies involving:

Dual GIP and GLP-1 receptor interactions
Glucose-dependent cellular signaling pathways
Peptide-receptor binding and activation
Insulin secretion response models
Glucagon regulation mechanisms
Incretin-associated metabolic signaling

Experimental outcomes may vary based on concentration, model selection, preparation method, study duration, and analytical procedures.

Storage Recommendations

Refrigerate unopened vials between 2°C and 8°C.
Store in a dry environment away from heat and direct light.
Use validated low-temperature conditions for extended preservation.
Maintain appropriate refrigeration after laboratory preparation.
Limit room-temperature exposure and unnecessary temperature changes.
Avoid repeated freeze-thaw cycles.
Refer to the Certificate of Analysis and institutional protocols.

Package Contents

Each package includes:

30mg of lyophilized Trizepatide
One sealed research vial
Product and lot identification details
Secure protective packaging

2 reviews for Tirzepatide 30mg

Rated 5 out of 5

Dr. Priya Chandran – May 21, 2026

Good documentation included with the shipment, matched our expectations.
Rated 4 out of 5

Owen Falkirk – July 1, 2026

Second order from this supplier, consistent so far.

Only logged in customers who have purchased this product may leave a review.